Taiwan's research and development of anti-cancer drugs have new breakthroughs in cervical cancer and gastric cancer

August 3rd: According to Taiwan media reports, new breakthroughs have been made in anti-cancer drugs! The Taiwan Institute of Health Research team developed new anti-cancer chemotherapy drugs. Through animal experiments, cervical cancer and gastric cancer were found to have significant inhibitory effects. The tumor volume was reduced by 84%.

According to reports, this pot of Taiwan-made anti-cancer drugs has made the Taiwan Institute of Health’s team grin. After eight years of research, the research team screened various types of cancer and cancer cell lines, especially in cervical cancer and gastric cancer. Animal experiments have shown significant inhibitory effects. Ten weeks after the intravenous injection of the treated mice, the tumor cells were BEFORE and AFTER. Obviously, 2 cm became 0.8 cm, and the tumor volume was reduced by 84%.

The research team said that this is only a small CASE, and it is even more proud. Xie Xingbang: "Different mechanisms and the effect of inhibiting vascular hyperplasia can overcome this resistance."

The drug resistance feared by cancer patients has also been overcome. The first self-developed small-molecule anti-cancer drug, from research and development, pre-clinical toxicology, manufacturing process and production, all in Taiwan. At the end of July, it had already passed the review of the US Food and Drug Administration. The forthcoming clinical trial is expected to bring new opportunities for cancer patients.